Page last updated: 2024-09-05

enrasentan and atrial natriuretic factor

enrasentan has been researched along with atrial natriuretic factor in 1 studies

Compound Research Comparison

Studies (enrasentan)	Trials (enrasentan)	Recent Studies (post-2010) (enrasentan)	Studies (atrial natriuretic factor)	Trials (atrial natriuretic factor)	Recent Studies (post-2010) (atrial natriuretic factor)
32	2	0	15,455	1,105	1,760

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aiyar, N; Anderson, KM; Barone, FC; Coatney, RW; Nelson, AH; Ohlstein, EH; Olzinski, AR; Willette, RN; Woods, T	1

Other Studies

1 other study(ies) available for enrasentan and atrial natriuretic factor

Article	Year
Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction. Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:4 Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Carboxylic Acids; Endothelin Receptor Antagonists; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Indans; Male; Myocardium; Protein Precursors; Rats; Rats, Inbred SHR; Survival Rate; Ventricular Remodeling	2001

Article

Year

Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction.

Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:4

Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Carboxylic Acids; Endothelin Receptor Antagonists; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Indans; Male; Myocardium; Protein Precursors; Rats; Rats, Inbred SHR; Survival Rate; Ventricular Remodeling

2001